Flor Americas, a specialty biotech company, conceptualizing, developing, and distributing next-generation solutions for the animal and human endocannabinoid systems is partnering with Biosintex Laboratorios, a leading developer and manufacturer of pharmaceuticals in Argentina, to procure cannabinoid ingredients, like cannabidiol (CBD). Additionally, Flor Americas will secure Biosintex Laboratorios’ long-term cannabinoid supply agreements to commercialize its innovative formulations for Argentina’s burgeoning medical cannabis market. Recently, Biosintex Laboratorios received authorization to import CBD from a producer within Flor Americas’ network. That CBD will be used to develop one of the first medical cannabis products available in Argentina.
Mmp News Author, Medical Marijuana Program Connection, 08/01/2021 15:44:00